Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Rossitto

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancers|July 27, 2024
Management of Metastatic Renal Cell Carcinoma Following First-Line Immune Checkpoint Therapy Failure: A Systematic ReviewFausto Petrelli, Ivano Vavassori, Mauro Rossitto, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2025
An umbrella review of meta-analyses on smoking cessation and cancer survival: a brief reportFausto Petrelli, Antonio Ghidini, Mauro Rossitto, et al.
International Urology and Nephrology|April 21, 2026
Early versus deferred immunotherapy in urothelial carcinoma: a review of evidence and post-progression survivalFausto Petrelli, Antonio Ghidini, Ivano Vavassori, et al.
Cancer Epidemiology|May 16, 2024
Different prognosis of left compared to right breast cancer: A systematic review and meta-analysisFausto Petrelli, Antonio Ghidini, Maria Antista, et al.
Translational Lung Cancer Research|September 15, 2025
A systematic review and network meta-analysis of immune checkpoint inhibitors in operable NSCLC: neoadjuvant, adjuvant, or perioperative?Fausto Petrelli, Lorenzo Dottorini, Mauro Rossitto, et al.
Tumori|June 6, 2025
Adding immune checkpoint inhibitors to chemotherapy in elderly cancer patients: Beneficial for many but not all?Fausto Petrelli, Antonio Ghidini, Italo Sarno, et al.
Clinical Genitourinary Cancer|August 29, 2025
Reassessing the Evidence: Is Intensified Therapy Justified in Older Patients with Metastatic Hormone-Sensitive Prostate Cancer?Lorenzo Dottorini, Italo Sarno, Alessandro Iaculli, et al.
Public Health|August 27, 2025
Effect of aspirin use on cancer incidence and mortality: An updated systematic review and meta-analysisFausto Petrelli, Antonio Ghidini, Maria Antista, et al.
Journal of Clinical Medicine|September 27, 2025
Immune Checkpoint Inhibitors Beyond Progression in Various Solid Tumors: A Systematic Review and Pooled AnalysisFausto Petrelli, Antonio Ghidini, Maria Chiara Parati, et al.
Critical Reviews in Oncology/Hematology|February 7, 2026
Real-World Evidence for 10 Oncology Drugs Approved in the last 5 years: A Comprehensive Narrative SynthesisFausto Petrelli, Lara Colombo Zefinetti, Maria Chiara Parati, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancers|July 27, 2024
Management of Metastatic Renal Cell Carcinoma Following First-Line Immune Checkpoint Therapy Failure: A Systematic ReviewFausto Petrelli, Ivano Vavassori, Mauro Rossitto, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2025
An umbrella review of meta-analyses on smoking cessation and cancer survival: a brief reportFausto Petrelli, Antonio Ghidini, Mauro Rossitto, et al.
International Urology and Nephrology|April 21, 2026
Early versus deferred immunotherapy in urothelial carcinoma: a review of evidence and post-progression survivalFausto Petrelli, Antonio Ghidini, Ivano Vavassori, et al.
Cancer Epidemiology|May 16, 2024
Different prognosis of left compared to right breast cancer: A systematic review and meta-analysisFausto Petrelli, Antonio Ghidini, Maria Antista, et al.
Translational Lung Cancer Research|September 15, 2025
A systematic review and network meta-analysis of immune checkpoint inhibitors in operable NSCLC: neoadjuvant, adjuvant, or perioperative?Fausto Petrelli, Lorenzo Dottorini, Mauro Rossitto, et al.
Tumori|June 6, 2025
Adding immune checkpoint inhibitors to chemotherapy in elderly cancer patients: Beneficial for many but not all?Fausto Petrelli, Antonio Ghidini, Italo Sarno, et al.
Clinical Genitourinary Cancer|August 29, 2025
Reassessing the Evidence: Is Intensified Therapy Justified in Older Patients with Metastatic Hormone-Sensitive Prostate Cancer?Lorenzo Dottorini, Italo Sarno, Alessandro Iaculli, et al.
Public Health|August 27, 2025
Effect of aspirin use on cancer incidence and mortality: An updated systematic review and meta-analysisFausto Petrelli, Antonio Ghidini, Maria Antista, et al.
Journal of Clinical Medicine|September 27, 2025
Immune Checkpoint Inhibitors Beyond Progression in Various Solid Tumors: A Systematic Review and Pooled AnalysisFausto Petrelli, Antonio Ghidini, Maria Chiara Parati, et al.
Critical Reviews in Oncology/Hematology|February 7, 2026
Real-World Evidence for 10 Oncology Drugs Approved in the last 5 years: A Comprehensive Narrative SynthesisFausto Petrelli, Lara Colombo Zefinetti, Maria Chiara Parati, et al.
Pageof 2